Re-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literature

Author：        

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|5|2419-2421

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.5, 2015-01, pp. : 2419-2421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rechallenge with gefitinib following severe druginduced hepatotoxicity in a patient with advanced nonsmall cell lung cancer: A case report and literature review

By              

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 878-880

Spandidos Publications

Access to resources Recommend Favorite

Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature

By        

Experimental and Therapeutic Medicine, Vol. 11, Iss. 1, 2016-01 ,pp. : 197-200

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

By                  

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite

Ulcerative colitis combined with acute interstitial lung disease and airway disease: A case report and literature review

By          

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1229-1236

Spandidos Publications

Access to resources Recommend Favorite

Hand-foot syndrome in a patient with metastatic lung adenocarcinoma induced by high-dose icotinib: A case report and review of the literature

By Zheng Yulong   Fang Weijia   Xu Nong  

Oncology Letters, Vol. 4, Iss. 6, 2012-12 ,pp. : 1341-1343

Spandidos Publications

Access to resources Recommend Favorite